SOOLANTRA

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Lithuania, Malta, Netherlands, Poland, Romania, Singapore, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug SOOLANTRA contains one active pharmaceutical ingredient (API):

1	Ivermectin UNII 8883YP2R6D - IVERMECTIN
	Ivermectin is a member of the avermectin class and has high affinity with glutamate-gated chloride channels present in invertebrate nerve and muscle cells. Its binding to these channels promotes an increase in membrane permeability to chloride ions, leading to hyperpolarization of the neural or muscle cell. This results in neuromuscular paralysis and may lead to the death of certain parasites.
	Read more about Ivermectin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SOOLANTRA Cream	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D11AX22		D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AX Other dermatologicals
Discover more medicines within D11AX22

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	510120070005907
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	4549-MEE-0119
EE	Ravimiamet	1644724, 1644735, 1644746, 1644757, 1644768
ES	Centro de información online de medicamentos de la AEMPS	79911
FI	Lääkealan turvallisuus- ja kehittämiskeskus	058790, 119528
FR	Base de données publique des médicaments	69444281
GB	Medicines & Healthcare Products Regulatory Agency	297364
HK	Department of Health Drug Office	64980
IE	Health Products Regulatory Authority	38602, 38693
IL	מִשְׂרַד הַבְּרִיאוּת	8790, 8791, 8946
LT	Valstybinė vaistų kontrolės tarnyba	1073154, 1076602, 1076603, 1076604, 1076605
MT	Medicines Authority	MA117/01101
NL	Z-Index G-Standaard	16211286
NL	Z-Index G-Standaard, PRK	129674
PL	Rejestru Produktów Leczniczych	100341880
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W61758001, W61758002, W61758003, W61758004, W61758005
SG	Health Sciences Authority	15197P
TN	Direction de la Pharmacie et du Médicament	7393121
TR	İlaç ve Tıbbi Cihaz Kurumu	8680530820136
US	FDA, National Drug Code	0299-3823